Collie Eye Anomaly Screening Notes

Collie eye anomaly is diagnosed by an ophthalmoscopic eye exam, most often between six and eight weeks of age, and graded by how much of the choroid failed to develop. A DNA test for the NHEJ1 mutation on chromosome 37 identifies carriers, but the visible grade, not the genotype alone, determines how severely a dog is affected. Breeders use both results together: an affected or carrier dog is paired with a genetically clear mate rather than removed from a program.

How is collie eye anomaly diagnosed and graded?

Diagnosis starts with a direct ophthalmoscope and a darkened room. The examiner looks at the fundus, the back of the eye, for a pale patch where the choroid, the vascular layer under the retina, did not form completely. That finding is choroidal hypoplasia, the hallmark lesion of collie eye anomaly, and it is present in the great majority of affected dogs.

The grade describes how much tissue is missing and whether other structures are involved. Mild choroidal hypoplasia is a small, well-defined pale area near the optic disc. More extensive hypoplasia covers a wider region of the tapetal fundus. Coloboma, a pit or defect in or near the optic disc, and retinal detachment are the serious complications, and they carry the highest risk of vision loss. A dog can be graded mildly and still see normally for life; a dog with a coloboma or a detached retina may not.

Age matters. Puppies are screened young because the pigmentation that develops over the first months of life can mask the pale patch, a phenomenon called apparent normalization. A dog examined at eight weeks may show clear choroidal hypoplasia, while the same dog examined at one year can look unremarkable. For that reason, certificates record the age at examination, and a normal result in an adult dog without a puppy exam is not proof the dog is clear. Optical coherence tomography, which images the retinal layers in cross section, is used in referral settings to document the lesion more precisely than a handheld scope can.

Owners and breeders who want the full clinical picture, including how grading scales are read on a certificate, can find it at collie eye anomaly grading, which covers the ophthalmoscope exam, tomography, and the age-related normalization effect.

Which breeds and crosses are screened for the mutation?

Collie eye anomaly is a recessive trait, so a dog needs two copies of the NHEJ1 mutation to be at risk of the classic form. Screening is concentrated in the herding breeds where the mutation is common: rough and smooth collies, border collies, Australian shepherds, Shetland sheepdogs, Lancashire heelers, and Nova Scotia duck tolling retrievers.

Crosses are screened too. Because the mutation is recessive and widespread in these lines, a doodle or a sport mix with a border collie or Australian shepherd parent can inherit one copy or two. Breeders of crosses that advertise herding ancestry generally test the parent dogs, and buyers can ask for those results.

Kennel club requirements vary by country. Some clubs accept a DNA test result alone for registration or breeding approval; others expect an annual or lifetime eye certificate from a veterinary ophthalmologist. Prevalence data collected internationally show the mutation is not evenly distributed, which is why a test result from one line tells you little about another. A dog from a line with no history of the condition can still be a carrier.

What does a breeding plan do with a carrier result?

A carrier result, one copy of the mutation, does not mean the dog should be removed from breeding. It means the dog should be paired with a dog that tested clear.

A carrier bred to a clear dog produces, on average, half clear puppies and half carrier puppies. No puppy from that pairing is at risk of the two-copy form, so no puppy inherits the classic disease from that mating alone. Every puppy in the litter can be tested, and the clear puppies can be used more freely in the next generation while carriers are again paired with clear dogs.

Breeding two carriers is the combination to avoid. That pairing gives each puppy a one in four chance of inheriting two copies of the mutation. Breeding an affected dog, one with two copies, to a clear dog also avoids producing at-risk puppies, though the affected dog's own eye grade and comfort should guide whether it is bred at all.

The practical plan is a rolling one: test every dog before it is bred, record the genotype alongside the eye certificate, and match carriers to clears until the mutation is worked out of the line. Modifier genes influence how severe the visible lesion becomes, so two dogs with the same genotype can grade differently. That is why a DNA result never replaces the eye exam.

What does daily life look like with an affected dog?

Most dogs with mild choroidal hypoplasia live normal lives. The lesion is stable, the dog sees well, and the main task is periodic eye exams rather than treatment. Many owners never notice anything unusual.

Dogs with coloboma or retinal detachment are a different case. Vision loss can be partial or complete, and a detached retina is a medical situation that needs prompt veterinary attention. Blind dogs adapt well when their environment stays predictable: furniture in fixed positions, gates on stairs, verbal cues instead of hand signals, and leashes in unfamiliar places. Scent work, obedience, and other low-impact activities remain open to them.

Nutrition and general conditioning support the dog the same way they support any dog, and there is no diet that reverses the choroidal lesion. Owners should be skeptical of surgical fixes marketed for the condition; the structural defect is developmental, not something a procedure restores. For working and sport dogs, the decision usually comes down to the individual dog's grade and how well it navigates its usual routes.

Do all affected dogs lose their vision?

No. The grade predicts risk, not destiny. A large share of affected dogs have choroidal hypoplasia alone and keep functional vision for their whole lives. Coloboma raises the risk of detachment and of vision loss, and detachment itself is the event that most often costs a dog its sight. Regular examinations let an owner and a veterinarian track changes rather than guess at them.

Why the DNA test and the eye exam are both needed

The DNA test tells a breeder what a dog can pass on. The eye exam tells an owner what the dog can see and how likely that is to change. Used together, they support breeding decisions that reduce the frequency of the mutation without narrowing the gene pool, and they give owners of affected dogs a realistic picture of what to expect. Puppy screening, certificates that record the age at examination, and genotype results kept with the dog's records are the three pieces that make the system work.

The MDR1 mutation removes part of a dog's normal blood-brain barrier pump, so certain drugs reach the brain at far higher concentrations than in a dog without the mutation. That single change explains why a standard dose of ivermectin or a routine anaesthetic protocol can cause tremors, ataxia, blindness or coma in affected Collies, Australian Shepherds and related breeds. Owners who know their dog's MDR1 status can hand a veterinarian a concrete list of molecules to avoid, which is the practical core of macrocyclic lactones explained. Before anaesthesia or a preventive treatment, an owner should confirm the dog's MDR1 status and review the avoid list with the veterinarian.